Keywords: epirubicin, cleared, usa, node-positive, early, breast, cancer
Epirubicin cleared in USA for node-positive early breast cancer
Article | 21 September 1999
Pharmacia & Upjohn's Ellence (epirubicin hydrochloride injection) hasbeen approved in the USA as an adjuvant therapy, following surgery, in patients with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
